Ahmed S Abdelsamie

6PUBLICATIONS
14CO-AUTHORS
Pharmaceutical delivery technologiesMedical infection agents (incl. prions)Clinical pharmacology and therapeuticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 05, 2026
Multiparameter Optimization of Pseudomonas aeruginosa Elastase Inhibitors for Systemic Administration.

Ahmed S Abdelsamie, Jelena Konstantinović, Andreas M Kany

|Jan 01, 2024
Inhibitors of the Elastase LasB for the Treatment of Pseudomonas aeruginosa Lung Infections.

Jelena Konstantinović, Andreas M Kany, Alaa Alhayek

|Jun 27, 2023
Potent Dual Inhibitors of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 with a Suitable Pharmacokinetic Profile for In Vivo Proof-of-Principle Studies in an Endometriosis Mouse Model.

Mohamed Salah, Mariam Tahoun, Jeannette Rudzitis-Auth

|Aug 22, 2022
Dual Targeting of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 by a Novel Drug-Prodrug Approach: A Potential Therapeutic Option for the Treatment of Endometriosis.

Abdelrahman Mohamed, Mohamed Salah, Mariam Tahoun

|Jul 26, 2019
Design, Synthesis, and Biological Characterization of Orally Active 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors Targeting the Prevention of Osteoporosis.

Ahmed S Abdelsamie, Mohamed Salah, Lorenz Siebenbürger

|Jan 16, 2019
Targeted Endocrine Therapy: Design, Synthesis, and Proof-of-Principle of 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors in Bone Fracture Healing.

Ahmed S Abdelsamie, Steven Herath, Yannik Biskupek

Pageof 1

Frequent Collaborators

4 joint publications

Martin Frotscher

3 joint publications

Mohamed Salah

3 joint publications

Rolf W Hartmann

3 joint publications

Chris J van Koppen